Cytokinetics, Inc. (CYTK)
51.08
-0.38
(-0.74%)
USD |
NASDAQ |
Nov 20, 15:09
Cytokinetics 30-Day Average Daily Volume : 1.896M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.896M |
| November 18, 2026 | 1.925M |
| November 17, 2026 | 1.951M |
| November 16, 2026 | 1.969M |
| November 13, 2026 | 2.018M |
| November 12, 2026 | 2.072M |
| November 11, 2026 | 2.063M |
| November 10, 2026 | 2.068M |
| November 09, 2026 | 2.070M |
| November 06, 2026 | 2.051M |
| November 05, 2026 | 2.019M |
| November 04, 2026 | 1.854M |
| November 03, 2026 | 1.825M |
| November 02, 2026 | 1.848M |
| October 30, 2026 | 1.850M |
| October 29, 2026 | 1.970M |
| October 28, 2026 | 1.969M |
| October 27, 2026 | 2.001M |
| October 26, 2026 | 2.048M |
| October 23, 2026 | 2.073M |
| October 22, 2026 | 2.098M |
| October 21, 2026 | 2.077M |
| October 20, 2026 | 2.089M |
| October 19, 2026 | 2.118M |
| October 16, 2026 | 2.092M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.105M |
| October 14, 2026 | 2.103M |
| October 13, 2026 | 2.096M |
| October 12, 2026 | 2.134M |
| October 09, 2026 | 2.238M |
| October 08, 2026 | 2.238M |
| October 07, 2026 | 2.192M |
| October 06, 2026 | 2.155M |
| October 05, 2026 | 2.087M |
| October 02, 2026 | 2.030M |
| October 01, 2026 | 1.997M |
| September 30, 2026 | 1.990M |
| September 29, 2026 | 1.945M |
| September 28, 2026 | 1.915M |
| September 25, 2026 | 1.889M |
| September 24, 2026 | 1.894M |
| September 23, 2026 | 1.903M |
| September 22, 2026 | 1.877M |
| September 21, 2026 | 1.873M |
| September 18, 2026 | 1.940M |
| September 17, 2026 | 1.862M |
| September 16, 2026 | 1.868M |
| September 15, 2026 | 1.876M |
| September 14, 2026 | 1.865M |
| September 11, 2026 | 1.867M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| BridgeBio Pharma, Inc. | 2.799M |
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Arrowhead Pharmaceuticals, Inc. | 2.135M |
| BioMarin Pharmaceutical, Inc. | 2.551M |
| Exelixis, Inc. | 2.776M |